Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.40 |
| ▸ | SETD7 | Q8WTS6 | 2/20 | 0.39 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12021385 | 1.00 | TSHR (0.50) | TSHRGPR119SETD7NR1H2CHRM2 | |
| SCHEMBL24779803 | 1.00 | TSHR (0.50) | TSHRGPR119SETD7NR1H2CHRM2 | |
| SCHEMBL27031154 | 0.94 | TSHR (0.44) | TSHRGPR119SETD7NR1H2CHRM2 | |
| SCHEMBL271429 | 0.89 | TSHR (0.56) | TSHRGPR119SETD7NR1H2CHRM2 | |
| SCHEMBL527701 | 0.89 | TSHR (0.56) | TSHRGPR119SETD7NR1H2CHRM2 | |
| SCHEMBL344752 | 0.89 | TSHR (0.56) | TSHRGPR119SETD7NR1H2CHRM2 | |
| SCHEMBL30591044 | 0.82 | TSHR (0.50) | TSHRGPR119SETD7NR1H2CHRM2 | |
| SCHEMBL24685136 | 0.82 | TSHR (0.50) | TSHRGPR119SETD7NR1H2CHRM2 | |
| SCHEMBL29942260 | 0.82 | TSHR (0.50) | TSHRGPR119SETD7NR1H2CHRM2 | |
| SCHEMBL24684727 | 0.82 | TSHR (0.50) | TSHRGPR119SETD7NR1H2CHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118302413-A | Anti-SARS-CoV-2 medicine | 国立大学法人鹿儿岛大学 | 2024-07-05 | — | — | CN | disclosed |